- call +1-201-465-4211
- email sales@mrinsights.biz
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
Scope of the Report:
This report studies the Cancer Stem Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Stem Cells market by product type and applications/end industries.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
The global Cancer Stem Cells market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Stem Cells.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Market Segment by Applications, can be divided into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cancer Stem Cells Market Overview
1.1 Product Overview and Scope of Cancer Stem Cells
1.2 Classification of Cancer Stem Cells by Types
1.2.1 Global Cancer Stem Cells Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Stem Cells Revenue Market Share by Types in 2017
1.2.3 Cell Culturing
1.2.4 Cell Separation
1.2.5 Cell Analysis
1.2.6 Molecular Analysis
1.2.7 Others
1.3 Global Cancer Stem Cells Market by Application
1.3.1 Global Cancer Stem Cells Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Others
1.4 Global Cancer Stem Cells Market by Regions
1.4.1 Global Cancer Stem Cells Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Stem Cells Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Stem Cells Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Stem Cells Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Stem Cells Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Stem Cells Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Stem Cells (2013-2023)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Business Overview
2.1.2 Cancer Stem Cells Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbvie
2.2.1 Business Overview
2.2.2 Cancer Stem Cells Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbvie Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck Kgaa
2.3.1 Business Overview
2.3.2 Cancer Stem Cells Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Kgaa Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bionomics
2.4.1 Business Overview
2.4.2 Cancer Stem Cells Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bionomics Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lonza
2.5.1 Business Overview
2.5.2 Cancer Stem Cells Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lonza Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.6 Stemline Therapeutics
2.6.1 Business Overview
2.6.2 Cancer Stem Cells Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Stemline Therapeutics Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.7 Miltenyi Biotec
2.7.1 Business Overview
2.7.2 Cancer Stem Cells Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Miltenyi Biotec Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.8 Promocell
2.8.1 Business Overview
2.8.2 Cancer Stem Cells Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Promocell Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.9 Macrogenics
2.9.1 Business Overview
2.9.2 Cancer Stem Cells Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Macrogenics Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.10 Oncomed Pharmaceuticals
2.10.1 Business Overview
2.10.2 Cancer Stem Cells Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.11 Irvine Scientific
2.11.1 Business Overview
2.11.2 Cancer Stem Cells Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Irvine Scientific Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.12 Stemcell Technologies
2.12.1 Business Overview
2.12.2 Cancer Stem Cells Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Stemcell Technologies Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sino Biological
2.13.1 Business Overview
2.13.2 Cancer Stem Cells Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sino Biological Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
2.14 Biotime
2.14.1 Business Overview
2.14.2 Cancer Stem Cells Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Biotime Cancer Stem Cells Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Stem Cells Market Competition, by Players
3.1 Global Cancer Stem Cells Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Stem Cells Players Market Share
3.2.2 Top 10 Cancer Stem Cells Players Market Share
3.3 Market Competition Trend
4 Global Cancer Stem Cells Market Size by Regions
4.1 Global Cancer Stem Cells Revenue and Market Share by Regions
4.2 North America Cancer Stem Cells Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Stem Cells Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Stem Cells Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Stem Cells Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Stem Cells Revenue and Growth Rate (2013-2018)
5 North America Cancer Stem Cells Revenue by Countries
5.1 North America Cancer Stem Cells Revenue by Countries (2013-2018)
5.2 USA Cancer Stem Cells Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Stem Cells Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Stem Cells Revenue and Growth Rate (2013-2018)
6 Europe Cancer Stem Cells Revenue by Countries
6.1 Europe Cancer Stem Cells Revenue by Countries (2013-2018)
6.2 Germany Cancer Stem Cells Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Stem Cells Revenue and Growth Rate (2013-2018)
6.4 France Cancer Stem Cells Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Stem Cells Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Stem Cells Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Stem Cells Revenue by Countries
7.1 Asia-Pacific Cancer Stem Cells Revenue by Countries (2013-2018)
7.2 China Cancer Stem Cells Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Stem Cells Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Stem Cells Revenue and Growth Rate (2013-2018)
7.5 India Cancer Stem Cells Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Stem Cells Revenue and Growth Rate (2013-2018)
8 South America Cancer Stem Cells Revenue by Countries
8.1 South America Cancer Stem Cells Revenue by Countries (2013-2018)
8.2 Brazil Cancer Stem Cells Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Stem Cells Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Stem Cells Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Stem Cells by Countries
9.1 Middle East and Africa Cancer Stem Cells Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Stem Cells Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Stem Cells Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Stem Cells Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Stem Cells Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Stem Cells Revenue and Growth Rate (2013-2018)
10 Global Cancer Stem Cells Market Segment by Type
10.1 Global Cancer Stem Cells Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Stem Cells Market Forecast by Type (2018-2023)
10.3 Cell Culturing Revenue Growth Rate (2013-2023)
10.4 Cell Separation Revenue Growth Rate (2013-2023)
10.5 Cell Analysis Revenue Growth Rate (2013-2023)
10.6 Molecular Analysis Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Cancer Stem Cells Market Segment by Application
11.1 Global Cancer Stem Cells Revenue Market Share by Application (2013-2018)
11.2 Cancer Stem Cells Market Forecast by Application (2018-2023)
11.3 Breast Cancer Diagnosis and Treatment Revenue Growth (2013-2018)
11.4 Prostate Cancer Diagnosis and Treatment Revenue Growth (2013-2018)
11.5 Colorectal Cancer Diagnosis and Treatment Revenue Growth (2013-2018)
11.6 Lung Cancer Diagnosis and Treatment Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Cancer Stem Cells Market Size Forecast (2018-2023)
12.1 Global Cancer Stem Cells Market Size Forecast (2018-2023)
12.2 Global Cancer Stem Cells Market Forecast by Regions (2018-2023)
12.3 North America Cancer Stem Cells Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Stem Cells Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Stem Cells Revenue Market Forecast (2018-2023)
12.6 South America Cancer Stem Cells Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Stem Cells Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cancer Stem Cells Picture
Table Product Specifications of Cancer Stem Cells
Table Global Cancer Stem Cells and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
